Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neuroone Medical Technologies (NMTC) Revenue (2020 - 2026)

Neuroone Medical Technologies filings provide 12 years of Revenue readings, the most recent being $2.4 million for Q1 2026.

  • On a quarterly basis, Revenue rose 72.46% to $2.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was $9.7 million, a 68.8% increase, with the full-year FY2025 number at $9.1 million, up 163.47% from a year prior.
  • Revenue hit $2.4 million in Q1 2026 for Neuroone Medical Technologies, down from $2.9 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $3.3 million in Q4 2024 to a low of $32049.0 in Q2 2022.
  • Median Revenue over the past 5 years was $825776.0 (2024), compared with a mean of $1.2 million.
  • Biggest five-year swings in Revenue: skyrocketed 1865.45% in 2023 and later crashed 63.29% in 2024.
  • Neuroone Medical Technologies' Revenue stood at $114579.0 in 2022, then skyrocketed by 753.25% to $977649.0 in 2023, then skyrocketed by 234.9% to $3.3 million in 2024, then dropped by 11.65% to $2.9 million in 2025, then dropped by 17.34% to $2.4 million in 2026.
  • The last three reported values for Revenue were $2.4 million (Q1 2026), $2.9 million (Q4 2025), and $2.7 million (Q3 2025) per Business Quant data.